HHS

Harte-Hanks, Inc.

Stock · NASDAQ

Program summary

FieldValueAs ofSource
Current authorization$7m30-Sep-2610-Q filed 13-Nov-26
Remaining authorization$4m30-Sep-2610-Q filed 13-Nov-26
Program expiryn/a—
Repurchased last quarter$030-Sep-2610-Q filed 13-Nov-26
Has used an ASRNo—

Programs

Authorized onAuthorizedRemainingExpiresTerms
02-May-23$7m$4mn/aOn May 2, 2023, the Board of Directors of the Company approved a share repurchase program to maximize shareholder value with authorization to repurchase $6.5 million of the Company’s Common Stock.10-Q filed 13-Nov-26

Open-market repurchases

Repurchased per month, USD (≈ shares × average price)
  1. ≈$0
    Jul ’26
  2. Aug ’26
  3. ≈$0
    Sep ’26
Month endedSharesAvg price≈ ValueSource
30-Sep-260—$010-Q filed 13-Nov-26
31-Aug-260—$010-Q filed 13-Nov-26
31-Jul-260—$010-Q filed 13-Nov-26
Filings through 30-Sep-26· checked 17-Nov-26